Philadelphia 76ers center Joel Embiid is heading into surgery this afternoon after being diagnosed with appendicitis in Houston, the team announced, dealing the franchise yet another injury blow at the worst possible moment in the season.
Embiid, a seven-time All-Star and the 2023 NBA Most Valuable Player, had reported feeling ill earlier in the day and was ruled out for Philadelphia’s game against the Houston Rockets before the team confirmed the diagnosis. Surgery is being performed in Houston, where the 76ers are in the middle of a three-game road trip. The team said further updates would be provided as appropriate but gave no immediate timeline for his return.
What this means for Philadelphia’s playoff hopes
With just three games remaining on the regular-season schedule, the timing could hardly be more difficult. The 76ers entered today at 43 wins and 36 losses, sitting eighth in the Eastern Conference standings. Philadelphia is virtually certain to participate in the Play-In Tournament but could still move up into the top six and secure a guaranteed playoff spot if the final stretch of games breaks the right way. That path becomes considerably harder without Embiid in the lineup.
The team travels to face the Indiana Pacers on Friday before returning home to close the regular season against the Milwaukee Bucks on Sunday. It is unclear whether Embiid will be available for either of those games following surgery.
This season, Embiid has averaged 26.9 points, 7.7 rebounds and 3.9 assists across 38 appearances. Today’s absence continues a pattern that has defined his career in Philadelphia. He has not played more than 40 games in a season since the 2022 to 2023 campaign, and his injury report status has been notoriously difficult to predict from game to game. In April alone, he played in games he was listed as doubtful for and missed games where he did not appear on the injury report at all.
The Sixers just ruled Joel Embiid OUT for tonight’s game against the Rockets. He has an illness.
— Adam Aaronson (@SixersAdam) April 9, 2026
The bigger picture around Embiid’s future
The appendicitis diagnosis arrives against a backdrop of growing questions about Embiid’s long-term fit in Philadelphia. He has played in 490 games since being drafted in 2014, missing nearly as many as he has played over the course of his career.
This is the third consecutive season in which Embiid will appear in 40 games or fewer, a trend that puts significant strain on a franchise that has structured much of its future around him. A three-year, $193 million contract extension he signed in September 2024 has not yet begun and is set to kick in next season, paying him more than $57 million in 2026 to 2027, more than $62 million the following year and carrying a player option worth $67 million for the 2028 to 2029 season.
The scale of that contract, combined with the availability concerns, has fueled speculation about whether the 76ers will consider moving Embiid in the offseason. An NBA front office analyst recently noted publicly that the contract is technically tradeable, pointing to comparable deals involving other high-salary players that were moved for packages of expiring contracts and future draft picks. Whether Philadelphia would pursue that kind of salary-clearing move, or what it might seek in return, remains an open question the organization has not publicly addressed.
For now, the immediate focus is on Embiid’s surgery and recovery, as the franchise tries to secure its postseason positioning with the limited roster options available to it over the final games of the regular season. Updates on his condition are expected from the team in the hours ahead.